Ngā hua rapu - S. REVEL‐VILK

Whakamahine hua
  1. 1
    Fertility preservation in young cancer patients

    Fertility preservation in young cancer patients mā Revel, Ariel, Revel-Vilk, Shoshana

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Patient blood management programs: how to spread the word?

    Patient blood management programs: how to spread the word? mā Revel-Vilk, Shoshana, Naamad, Mira

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review

    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review mā Shoshana Revel‐Vilk, Maria Fuller, Ari Zimran

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Impact of Gaucher disease on COVID‐19

    Impact of Gaucher disease on COVID‐19 mā Zimran, Ari, Szer, Jeff, Revel‐Vilk, Shoshana

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review

    Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review mā Revel-Vilk, Shoshana, Fuller, Maria, Zimran, Ari

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact

    A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact mā Zimran, Ari, Ruchlemer, Rosa, Revel-Vilk, Shoshana

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    How we manage Gaucher Disease in the era of choices

    How we manage Gaucher Disease in the era of choices mā Shoshana Revel‐Vilk, Jeff Szer, Atul Mehta, Ari Zimran

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease

    Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease mā Shoshana Revel‐Vilk, Anthony K.C. Chan, Mary Bauman, Patricia Massicotte

    I whakaputaina 2003
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Official communication of the SSC: Recommendations for future research in catheter‐related arterial thrombosis in children

    Official communication of the SSC: Recommendations for future research in catheter‐related arterial thrombosis in children mā Albisetti, Manuela, Rizzi, Mattia, Bonduel, Mariana, Revel‐Vilk, Shoshana, Goldenberg, Neil

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The clinical course of bronchiolitis associated with acute otitis media

    The clinical course of bronchiolitis associated with acute otitis media mā Shazberg, G., Revel-Vilk, S., Shoseyov, D., Ben-Ami, A., Klar, A., Hurvitz, H.

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Second bone marrow transplantation for patients with thalassemia: risks and benefits

    Second bone marrow transplantation for patients with thalassemia: risks and benefits mā Stepensky, Polina, Or, Reuven, Shapira, Michael Y, Revel-Vilk, Shoshana, Stein, Jerry, Resnick, Igor B.

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy

    A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replaceme... mā Noa Hurvitz, Tama Dinur, Shoshana Revel‐Vilk, Samuel Agus, Marc Berg, Ari Zimran, Yaron Ilan

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Anemia in Children with Down Syndrome

    Anemia in Children with Down Syndrome mā Tenenbaum, Ariel, Malkiel, Sarah, Wexler, Isaiah D., Levy-Khademi, Floris, Revel-Vilk, Shoshana, Stepensky, Polina

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene

    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene mā Eyal Shteyer, Ann Saada, Avraham Shaag, Fida’ Al‐Hijawi, Rojette Kidess, Shoshanah Revel-Vilk, Orly Elpeleg

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: a systematic review

    Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: a systematic review mā Sharathkumar, Anjali A., Biss, Tina, Kulkarni, Ketan, Ahuja, Sanjay, Regan, Matt, Male, Christoph, Revel-Vilk, Shoshana

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease

    Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease mā Dinur, Tama, Istaiti, Majdolen, Frydman, Dafna, Becker-Cohen, Michal, Szer, Jeff, Zimran, Ari, Revel-Vilk, Shoshana

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene

    Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene mā Shteyer, Eyal, Saada, Ann, Shaag, Avraham, Al-Hijawi, Fida' Aziz, Kidess, Rojette, Revel-Vilk, Shoshanah, Elpeleg, Orly

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations

    Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Fo... mā Dinur, Tama, Grittner, Ulrike, Revel-Vilk, Shoshana, Becker-Cohen, Michal, Istaiti, Majdolen, Cozma, Claudia, Rolfs, Arndt, Zimran, Ari

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease

    Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease mā Weill, Yishay, Zimran, Ari, Zadok, David, Wasser, Lauren M., Revel-Vilk, Shoshana, Hanhart, Joel, Dinur, Tama, Arkadir, David, Becker-Cohen, Michal

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Definition of post‐thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations

    Definition of post‐thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations mā Neil A. Goldenberg, Leonardo R. Brandão, Janna M. Journeycake, Susan R. Kahn, Paul Monagle, S. REVEL‐VILK, Anjali Sharathkumar, Anthony K.C. Chan

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: